Loading page…
Healthcare
CSL Ltd. holds an AlphaScore of 51/100 in the Healthcare sector, featuring a gross margin of 50.81% and a debt-to-equity ratio of 0.67. A primary strength of the company is its favorable momentum subscore of 79, indicating positive relative price strength. On the risk side, the company faces severe challenges with a negative return on equity (roe) of -15.84% and a negative net margin of -16.43%. The stock is priced at $32.21 with a market capitalization of $61.83 billion, forward price-to-earnings (pe) of 18.50, and a dividend of 2.25. Trailing PE is not available. Evidence is limited to the supplied 2026-10-11 snapshot data.
Written 11/10/2026, 00:38:56 UTC · Snapshot 11/10/2026